Transcutaneous Electrical Nerve Stimulation Market, By Product Type (Portable TENS and Table Top TENS), By Application Type (Chronic Pain and Acute Pain), By End-user Type (Hospitals, Physiotherapy Clinics, Rehabilitation Centers, Home care, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Jun 2024

Code : CMI7070

Pages :171

Formats :

Excel and PDF

Industry : Medical Devices

Market Concentration and Competitive Landscape

Transcutaneous Electrical Nerve Stimulation Market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Increasing preference for drug-free pain management solutions

The rising concerns regarding over-prescription and overuse of opioids and other pain medications have boosted interest in non-pharmacological pain management therapies. Various studies have shown a strong link between long-term use of opioids and risk of addiction, overdose, and death. Due to these risks, patients are showing heightened interest in exploring alternative treatment options for chronic pain that do not involve regular intake of pain medications. At the same time, certain population groups like pregnant women and elderly prefer avoiding medications during pregnancy and due to higher risk of side effects respectively. Transcutaneous electrical nerve stimulation provides a simple, drug-free and needle-free solution for managing both acute and chronic pain. TENS devices do not have major safety issues and risk of dependence like oral pain medications. This has increased their acceptability as first-line treatments for many painful conditions. The preference for safer pain management solutions without pharmaceutical dependencies is a key factor driving more patients and healthcare providers to consider TENS therapy. For instance, in September 2020, NeuroMetrix Inc., a provider of neurostimulation medical devices, launched the Quell App for Apple Watch users. This wearable TENS device is designed for knee, foot, and leg pain and is available over the counter (OTC).

Key Players Insights